Seeking Alpha

Nektar Therapeutics (NKTR): Q2 EPS of -$0.30 beats by $0.03. Revenue of $23.7M (+36.6% Y/Y)...

Nektar Therapeutics (NKTR): Q2 EPS of -$0.30 beats by $0.03. Revenue of $23.7M (+36.6% Y/Y) beats by $4M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)